跳到内容

血液科

再生障碍性(不良性)贫血

Eltrombopag added to immunosuppression in severe aplastic anemia. (打开新窗口)

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

来源‎: N Engl J Med 2022;386(1):11-23.

检索‎: PubMed 34986284

DOI码‎: 10.1056/NEJMoa2109965

https://pubmed.ncbi.nlm.nih.gov/34986284/ (打开新窗口)

Eltrombopag added to standard immunosuppression for aplastic anemia. (打开新窗口)

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

来源‎: N Engl J Med 2017;376(16):1540-50.

检索‎: PubMed 28423296

DOI码‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296 (打开新窗口)